Literature DB >> 24633162

CD4-positive T-cell recruitment in primary-provoked localized vulvodynia: potential insights into disease triggers.

Catherine M L Leclair1, Nicky J Leeborg, Erick Jacobson-Dunlop, Martha F Goetsch, Terry K Morgan.   

Abstract

OBJECTIVE: To better understand the potential disease triggers of neurogenic inflammation in provoked localized vulvodynia (PLV), our objective was to determine whether the types of infiltrating lymphocytes were different in vestibular biopsies from women with primary PLV, secondary PLV, and unaffected controls.
METHODS: Secondary retrospective analysis of archived vestibular biopsies from a series of adult premenopausal women with primary PLV (n = 10), secondary PLV (n = 10), and unaffected controls (n = 4) was performed. All study patients had severe entry dyspareunia for more than 1 year. Subjects were excluded if pregnant, or they had a known infection, or history of generalized vulvodynia. Biopsies were performed during the midfollicular phase. Lymphocyte subtypes were highlighted in histologic sections using antibodies against CD3, CD4, and CD8 and scored as the mean number of T-cell subtypes per high-power field. Flow cytometry was also used to test fresh biopsies from a de novo prospective series of primary PLV (n = 4) and unaffected controls (n = 2).
RESULTS: Unaffected control biopsies showed more CD8-positive than CD4-positive T cells, similar to previous reports of the gynecologic tract. In contrast, biopsies from women with primary PLV showed significantly more CD4-positive T cells than those from women with secondary PLV and unaffected controls (p = .003). This observation was further supported by flow cytometry.
CONCLUSIONS: CD4-positive T cells are more numerous in vestibular biopsies from premenopausal women with primary PLV. This may be important because subtypes of CD4-positive T cells are specifically recruited by infectious, allergic, or autoimmune triggers. Future studies distinguishing these subtypes may lead to new insights into this common disease.

Entities:  

Mesh:

Year:  2014        PMID: 24633162     DOI: 10.1097/LGT.0b013e3182a55591

Source DB:  PubMed          Journal:  J Low Genit Tract Dis        ISSN: 1089-2591            Impact factor:   1.925


  11 in total

1.  A Local Inflammatory Renin-Angiotensin System Drives Sensory Axon Sprouting in Provoked Vestibulodynia.

Authors:  Zhaohui Liao; Anuradha Chakrabarty; Ying Mu; Aritra Bhattacherjee; Martha Goestch; Catherine M Leclair; Peter G Smith
Journal:  J Pain       Date:  2017-01-03       Impact factor: 5.820

2.  Toll-Like Receptor Signaling Contributes to Proinflammatory Mediator Production in Localized Provoked Vulvodynia.

Authors:  Megan L Falsetta; David C Foster; Collynn F Woeller; Stephen J Pollock; Adrienne D Bonham; Dorota Piekna-Przybylska; Sanjay B Maggirwar; Constantine G Haidaris; Richard P Phipps
Journal:  J Low Genit Tract Dis       Date:  2018-01       Impact factor: 1.925

3.  Disease-Related Microstructural Differences in the Brain in Women With Provoked Vestibulodynia.

Authors:  Arpana Gupta; Davis C Woodworth; Benjamin M Ellingson; Andrea J Rapkin; Bruce Naliboff; Lisa A Kilpatrick; Jean Stains; Salome Masghati; Kirsten Tillisch; Emeran A Mayer; Jennifer S Labus
Journal:  J Pain       Date:  2018-01-31       Impact factor: 5.820

4.  A Role for Bradykinin Signaling in Chronic Vulvar Pain.

Authors:  Megan L Falsetta; David C Foster; Collynn F Woeller; Stephen J Pollock; Adrienne D Bonham; Constantine G Haidaris; Richard P Phipps
Journal:  J Pain       Date:  2016-08-18       Impact factor: 5.820

5.  Inflammatory Renin-Angiotensin System Disruption Attenuates Sensory Hyperinnervation and Mechanical Hypersensitivity in a Rat Model of Provoked Vestibulodynia.

Authors:  Anuradha Chakrabarty; Zhaohui Liao; Ying Mu; Peter G Smith
Journal:  J Pain       Date:  2017-12-25       Impact factor: 5.820

6.  Environmental Exposure History and Vulvodynia Risk: A Population-Based Study.

Authors:  Barbara D Reed; Kimberly S McKee; Melissa A Plegue; Sung Kyun Park; Hope K Haefner; Sioban D Harlow
Journal:  J Womens Health (Larchmt)       Date:  2018-10-10       Impact factor: 2.681

Review 7.  A review of the available clinical therapies for vulvodynia management and new data implicating proinflammatory mediators in pain elicitation.

Authors:  M L Falsetta; D C Foster; A D Bonham; R P Phipps
Journal:  BJOG       Date:  2016-06-17       Impact factor: 6.531

8.  Disease-related differences in resting-state networks: a comparison between localized provoked vulvodynia, irritable bowel syndrome, and healthy control subjects.

Authors:  Arpana Gupta; Andrea J Rapkin; Zafar Gill; Lisa Kilpatrick; Connor Fling; Jean Stains; Salome Masghati; Kirsten Tillisch; Emeran A Mayer; Jennifer S Labus
Journal:  Pain       Date:  2015-05       Impact factor: 7.926

9.  Specialized Pro-resolving Mediators Reduce Pro-nociceptive Inflammatory Mediator Production in Models of Localized Provoked Vulvodynia.

Authors:  Megan L Falsetta; Ronald W Wood; Mitchell A Linder; Adrienne D Bonham; Kenneth V Honn; Krishna Rao Maddipati; Richard P Phipps; Constantine G Haidaris; David C Foster
Journal:  J Pain       Date:  2021-04-01       Impact factor: 5.383

Review 10.  Localized Provoked Vulvodynia-An Ignored Vulvar Pain Syndrome.

Authors:  Jorma Paavonen; David A Eschenbach
Journal:  Front Cell Infect Microbiol       Date:  2021-06-17       Impact factor: 5.293

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.